SCHEMBL19081075

SCHEMBL19081075

CC1(C)c2ccccc2-c2c1c(-c1c3ccccc3c(-c3ccccc3)c3ccccc13)cc1sc3cc4ccccc4cc3c21

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.34
WEE1 P30291 1/20 0.34
ESR1 P03372 4/20 0.33
ESR2 Q92731 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081176 0.88 CHEK1 (0.34) CHEK1WEE1ESR1ESR2
SCHEMBL17945760 0.83 CHEK1 (0.38) CHEK1WEE1
SCHEMBL19081259 0.82 S1PR5 (0.31) CHEK1WEE1
SCHEMBL19081398 0.81 CHEK1 (0.30) CHEK1WEE1
SCHEMBL19081309 0.81 CA12 (0.32)
SCHEMBL19081277 0.81 CYP1A1 (0.37)
SCHEMBL19081150 0.81 CYP1A1 (0.39) CHEK1WEE1
SCHEMBL17945149 0.81 S1PR5 (0.33) CHEK1WEE1
SCHEMBL19081273 0.80 CYP1A1 (0.38)
SCHEMBL19081118 0.80 ESR1 (0.32) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CHEK1 255/4885WEE1 683/4885ESR1 225/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CHEK1 255/4885WEE1 683/4885ESR1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.